zoledronic acid has been researched along with Orphan Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asha, HS; Cherian, KE; Paul, TV; Rajan, R | 1 |
| Bezaury, AP; Nevarez-Barragan, MJ; Perez-Diaz, I; Rosas-Jurado, MG; Trejo-Rosales, R | 1 |
| Gehlen, M; Hinz, C; Lazarescu, AD; Maier, A; Pfeifer, M; Schmidt, N; Schwarz-Eywill, M; Weidemann, HF; Werner, M | 1 |
3 other study(ies) available for zoledronic acid and Orphan Diseases
| Article | Year |
|---|---|
McCune Albright syndrome: an endocrine medley.
Topics: Adenoma; Bone Density Conservation Agents; Cabergoline; Diagnosis, Differential; Dopamine Agonists; Female; Fibrous Dysplasia, Polyostotic; Humans; Hyperthyroidism; Leg; Musculoskeletal Pain; Pituitary Neoplasms; Rare Diseases; Young Adult; Zoledronic Acid | 2019 |
Rare association between penile squamous cell carcinoma and parathyroid related peptide (PTH-rP) secretion.
Topics: Bone Density Conservation Agents; Carcinoma, Squamous Cell; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Parathyroid Hormone; Pelvis; Penile Neoplasms; Rare Diseases; Tomography, X-Ray Computed; Zoledronic Acid | 2014 |
[Severe therapy refractive osteoporosis : A rare differential diagnosis].
Topics: Adult; Anti-Inflammatory Agents; Bone Density Conservation Agents; Chronic Disease; Diagnosis, Differential; Diphosphonates; Female; Humans; Imidazoles; Male; Mastocytosis, Systemic; Middle Aged; Osteoporosis; Rare Diseases; Treatment Failure; Treatment Outcome; Zoledronic Acid | 2016 |